Free Trial Information
BioCentury | Feb 3, 2016
Financial News

Qiming closes Fund V at $648 million

...Shanghai, China), cell analysis tools company Acea Biosciences Inc. (San Diego, Calif.) and vaccine company Tianjin CanSino Biotechnology Inc....
Read More
BioCentury | Nov 9, 2015
Financial News

Tianjin CanSino Biotechnology completes venture financing

Tianjin CanSino Biotechnology Inc. , Tianjin, China Business: Infectious Date completed: 2015-10-30 Type: Venture financing Raised: $30 million Investors: Qiming Venture Partners; Lilly Asia Ventures; existing investors WIR Staff...
Read More
BioCentury | Nov 4, 2015
Financial News

CanSino raises $30M in third round

Tianjin CanSino Biotechnology Inc. (Tianjin, China) said it raised about $30 million in its third round of venture funding. Qiming Venture Partners led the round, while Lilly Asia Ventures and other existing investors also participated....
Read More
BioCentury | Sep 23, 2013
Financial News

Tianjin CanSino Biotechnology completes venture financing

Tianjin CanSino Biotechnology Inc. , Tianjin, China Business: Infectious Date completed: 9/16/13 Type: Venture financing Raised: $10 million Investor: Lilly Asia Ventures WIR Staff Infectious...
Read More
BioCentury | Sep 18, 2013
Financial News

CanSino raises $10M from Lilly Asia Ventures

...Vaccine company Tianjin CanSino Biotechnology Inc. (Tianjin, China) raised $10 million in a financing from Lilly Asia Ventures. CanSino...
Read More
Items per page:
1 - 5 of 5
BioCentury | Feb 3, 2016
Financial News

Qiming closes Fund V at $648 million

...Shanghai, China), cell analysis tools company Acea Biosciences Inc. (San Diego, Calif.) and vaccine company Tianjin CanSino Biotechnology Inc....
Read More
BioCentury | Nov 9, 2015
Financial News

Tianjin CanSino Biotechnology completes venture financing

Tianjin CanSino Biotechnology Inc. , Tianjin, China Business: Infectious Date completed: 2015-10-30 Type: Venture financing Raised: $30 million Investors: Qiming Venture Partners; Lilly Asia Ventures; existing investors WIR Staff...
Read More
BioCentury | Nov 4, 2015
Financial News

CanSino raises $30M in third round

Tianjin CanSino Biotechnology Inc. (Tianjin, China) said it raised about $30 million in its third round of venture funding. Qiming Venture Partners led the round, while Lilly Asia Ventures and other existing investors also participated....
Read More
BioCentury | Sep 23, 2013
Financial News

Tianjin CanSino Biotechnology completes venture financing

Tianjin CanSino Biotechnology Inc. , Tianjin, China Business: Infectious Date completed: 9/16/13 Type: Venture financing Raised: $10 million Investor: Lilly Asia Ventures WIR Staff Infectious...
Read More
BioCentury | Sep 18, 2013
Financial News

CanSino raises $10M from Lilly Asia Ventures

...Vaccine company Tianjin CanSino Biotechnology Inc. (Tianjin, China) raised $10 million in a financing from Lilly Asia Ventures. CanSino...
Read More
Items per page:
1 - 5 of 5